BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16612635)

  • 1. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy.
    Charteris DG; Downie J; Aylward GW; Sethi C; Luthert P
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):93-100. PubMed ID: 16612635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
    Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
    Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
    Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations in the structure of the epiretinal membranes in PVR -- assumptions and reality].
    Vidinova C; Voinov L; Vidinov N
    Klin Monbl Augenheilkd; 2005 Jul; 222(7):568-71. PubMed ID: 16034724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of intraocular silicone oil: retina and epiretinal membranes.
    Wickham LJ; Asaria RH; Alexander R; Luthert P; Charteris DG
    Br J Ophthalmol; 2007 Feb; 91(2):258-62. PubMed ID: 17005544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
    Snead DR; James S; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of the ciliary epithelium with retinal neuronal and photoreceptor cell differentiation in human eyes with retinal detachment and proliferative vitreoretinopathy.
    Ducournau Y; Boscher C; Adelman RA; Guillaubey C; Schmidt-Morand D; Mosnier JF; Ducournau D
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):409-23. PubMed ID: 21932075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.
    Quiram PA; Gonzales CR; Hu W; Gupta A; Yoshizumi MO; Kreiger AE; Schwartz SD
    Ophthalmology; 2006 Nov; 113(11):2041-7. PubMed ID: 16952397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit retinal Müller cells undergo antigenic changes in response to experimentally induced proliferative vitreoretinopathy.
    McGillem GS; Dacheux RF
    Exp Eye Res; 1999 May; 68(5):617-27. PubMed ID: 10328976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening.
    Pastor JC; Méndez MC; de la Fuente MA; Coco RM; García-Arumí J; Rodríguez de la Rúa E; Fernández N; Saornil MA; Gayoso MJ
    Ophthalmic Res; 2006; 38(4):193-200. PubMed ID: 16679807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhegmatogenous retinal detachment and conventional surgical treatment.
    Golubovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(1):161-6. PubMed ID: 23917750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment.
    Schwatz SD; Alexander R; Hiscott P; Gregor ZJ
    Ophthalmology; 1996 Feb; 103(2):323-8. PubMed ID: 8594521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraocular surgery for secondary retinal detachment in proliferative vitreoretinopathy].
    Pournaras CJ; Donati G
    Klin Monbl Augenheilkd; 1995 May; 206(5):339-42. PubMed ID: 7609381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitrectomy in proliferative vitreoretinopathy. Anatomical and functional results in 501 patients].
    Körner F; Böhnke M
    Klin Monbl Augenheilkd; 1995 Apr; 206(4):239-45. PubMed ID: 7791283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-speed, high-resolution spectral optical coherence tomography in patients after vitrectomy with internal limiting membrane peeling for proliferative vitreoretinopathy retinal detachment.
    Odrobina DC; Michalewska Z; Michalewski J; Nawrocki J
    Retina; 2010 Jun; 30(6):881-6. PubMed ID: 20182404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine green-assisted peeling of the epiretinal membrane in proliferative vitreoretinopathy.
    Sakamoto H; Yamanaka I; Kubota T; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):204-7. PubMed ID: 12644944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
    Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
    Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localisation of BDNF, NT4 and TrkB in proliferative vitreoretinopathy.
    Ghazi-Nouri SM; Ellis JS; Moss S; Limb GA; Charteris DG
    Exp Eye Res; 2008 May; 86(5):819-27. PubMed ID: 18405896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.